Shanghai Meiji Health Science and Technology Co., Ltd

计划入组 95 人 · 首次发布于 2020 年 12 月 3 日

The Efficacy of Treatment for Helicobacter Pylori Infection in Preschooler by Yoghurt With LG21

计划入组 140 人 · 首次发布于 2023 年 9 月 21 日

Evaluation of Predictive Factors for Ruptures of Meije Duo ™ Size 1 and 2 Femoral Stems in Hip Replacement Surgery

计划入组 256 人 · 首次发布于 2020 年 2 月 10 日

B-3 (Meiji Seika Pharma)

NA-2003

TS-2037

MEIJI CO., LTD.

Japan

MEIJI GAKUIN UNIVERSITY

Japan

MEIJI PHARMACEUTICAL UNIVERSITY

Japan

Meiji Seika Pharma Partners with MBC BioLabs to Accelerate Drug Discovery Innovation

Meiji Seika Pharma Launches Phase I Trial of ME3241, Novel PD-1 Agonist for Autoimmune Diseases

Lyric Bio Raises $6.6M to Revolutionize IVIg Production with Ultra-High-Density Bioreactors